CIK: 0001609251 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 18, 2025
Total Value ($000): $169 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 92,057 | $32 | 19.2% | $127.97 | +187.2% | COM | 91307C102 |
| EXEL | EXELIXIS INC | 965,866 | $32 | 19.0% | $18.73 | +73.2% | COM | 30161Q104 |
| CAH | CARDINAL HEALTH INC | 208,845 | $25 | 14.6% | $56.53 | +103.1% | COM | 14149Y108 |
| BIIB | BIOGEN INC | 108,923 | $17 | 9.9% | $267.94 | -37.0% | COM | 09062X103 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 105,803 | $13 | 7.7% | $123.54 | -4.6% | COM | G50871105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 2,117,390 | $12 | 7.2% | $22.16 | -56.7% | COM | 29251M106 |
| — | INDIVIOR PLC | 935,680 | $12 | 6.9% | $0.01 | — | COM | G4766E116 |
| BNTX | BIONTECH SE-ADR | 88,663 | $10 | 6.0% | $0.09 | — | COM | 09075V102 |
| SNY | SANOFI-ADR | 149,196 | $7 | 4.3% | $0.05 | — | COM | 80105N105 |
| ALKS | ALKERMES PLC | 238,136 | $7 | 4.1% | $18.83 | +52.7% | COM | G01767105 |
| VNDA | VANDA PHARMACEUTICALS INC | 378,762 | $2 | 1.1% | $5.16 | -7.0% | COM | 921659108 |
| — | MURAL ONCOLOGY PLC | 70,163 | $0 | 0.1% | $0.01 | — | COM | G63365103 |